Back to Search
JOSEPH BOYETT, D.O.
D.O.
Sports Medicine (Orthopaedic Surgery) Physician
NPI: 1326199530IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery Physician
Orthopaedic Surgery
Code: 207X00000X
DO-530(AL)DO530(AL)
Sports Medicine (Orthopaedic Surgery) PhysicianPrimary
Orthopaedic Surgery — Sports Medicine
Code: 207XX0005X
DO530(AL)
Education
OTHER
Class of 1996
Research & Publications (20)
Somatostatin-immunoreactive interneurons contribute to lateral inhibitory circuits in the dentate gyrus of control and epileptic rats.
PMID 11530846·Hippocampus·2001
7-preclinical
Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor Consortium.
PMID 19384687·J Biopharm Stat·2009
8-other
Treating childhood acute lymphoblastic leukemia without cranial irradiation.
PMID 19553647·N Engl J Med·2009
2-rct
A stochastic model for estimation of mutation rates in multiple-replication proliferation processes.
PMID 18846374·J Math Biol·2009
8-other
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
PMID 19065567·Pediatr Blood Cancer·2009
3-trial
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
PMID 18802947·Pediatr Blood Cancer·2008
4-observational
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study.
PMID 18281546·Clin Cancer Res·2008
3-trial
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.
PMID 18281665·J Clin Oncol·2008
3-trial
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
PMID 18417739·Neuro Oncol·2008
3-trial
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC).
PMID 18425516·Eur J Nucl Med Mol Imaging·2008
4-observational
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
PMID 18669462·J Clin Oncol·2008
2-rct
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.
PMID 17634493·J Clin Oncol·2007
3-trial
The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress.
PMID 17416804·AJNR Am J Neuroradiol·2007
8-other
Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.
PMID 17252186·J Neurooncol·2007
2-rct
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
PMID 17293590·Neuro Oncol·2007
3-trial
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.
PMID 18006772·Clin Cancer Res·2007
3-trial
A sequential procedure for monitoring clinical trials against historical controls.
PMID 16900551·Stat Med·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 28235 Al Highway 53
Ardmore, AL 35739 - Phone
- (256) 539-2728
Quick Facts
- NPI
- 1326199530
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile